🇺🇸 FDA
Patent

US 9107866

Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia coli

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9107866 (Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia coli) held by United States of America as represented by the Secretary of the Air Force expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K2039/54, A61K2039/543